Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1981
H-2 negative teratocarcinoma cells become H-2 positive when passaged in genetically resistant host mice
S Ostrand-Rosenberg, V L Cohan
Agents and Actions
|
November 1, 1992
Multiple antigen challenge produces pulmonary eosinophilia but not pulmonary hyperresponsiveness in actively sensitized guinea pigs
J W Watson, V L Cohan, A K Shay, et al.
Cellular Immunology
|
September 1, 1991
Interleukin-1 is a mucus secretagogue
V L Cohan, A L Scott, C A Dinarello, et al.
Biochemical Pharmacology
|
January 25, 1991
Mechanisms of mediator release from human skin mast cells upon stimulation by the bradykinin analog, [DArg0-Hyp3-DPhe7]bradykinin
V L Cohan, D W MacGlashan, J A Warner, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 1996
The in vivo pharmacology of CP-80, 633, a selective inhibitor of phosphodiesterase 4
C R Turner, V L Cohan, J B Cheng, et al.
The American Review of Respiratory Disease
|
October 1, 1989
Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin
V L Cohan, B J Undem, C C Fox, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1993
Antigen-mediated pulmonary eosinophilia in immunoglobulin G1-sensitized guinea pigs: eosinophil peroxidase as a simple specific marker for detecting eosinophils in bronchoalveolar lavage fluid
J B Cheng, J S Pillar, J T Shirley, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 1, 1987
Purification and characterization of human skin mast cells. Evidence for human mast cell heterogeneity
I D Lawrence, J A Warner, V L Cohan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 11, 1991
Protein kinase C modulates immunoglobulin E-mediated activation of human mast cells from lung and skin. I. Pharmacologic inhibition
W A Massey, V L Cohan, D W MacGlashan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 1996
In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633
V L Cohan, H J Showell, D A Fisher, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1981
H-2 negative teratocarcinoma cells become H-2 positive when passaged in genetically resistant host mice
S Ostrand-Rosenberg, V L Cohan
Agents and Actions
|
November 1, 1992
Multiple antigen challenge produces pulmonary eosinophilia but not pulmonary hyperresponsiveness in actively sensitized guinea pigs
J W Watson, V L Cohan, A K Shay, et al.
Cellular Immunology
|
September 1, 1991
Interleukin-1 is a mucus secretagogue
V L Cohan, A L Scott, C A Dinarello, et al.
Biochemical Pharmacology
|
January 25, 1991
Mechanisms of mediator release from human skin mast cells upon stimulation by the bradykinin analog, [DArg0-Hyp3-DPhe7]bradykinin
V L Cohan, D W MacGlashan, J A Warner, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 1996
The in vivo pharmacology of CP-80, 633, a selective inhibitor of phosphodiesterase 4
C R Turner, V L Cohan, J B Cheng, et al.
The American Review of Respiratory Disease
|
October 1, 1989
Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin
V L Cohan, B J Undem, C C Fox, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1993
Antigen-mediated pulmonary eosinophilia in immunoglobulin G1-sensitized guinea pigs: eosinophil peroxidase as a simple specific marker for detecting eosinophils in bronchoalveolar lavage fluid
J B Cheng, J S Pillar, J T Shirley, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 1, 1987
Purification and characterization of human skin mast cells. Evidence for human mast cell heterogeneity
I D Lawrence, J A Warner, V L Cohan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 11, 1991
Protein kinase C modulates immunoglobulin E-mediated activation of human mast cells from lung and skin. I. Pharmacologic inhibition
W A Massey, V L Cohan, D W MacGlashan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 1996
In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633
V L Cohan, H J Showell, D A Fisher, et al.
Page
of 2